Genetic Associations with Valvular Calcification and Aortic Stenosis

In a genomewide association study, a SNP in the LPA locus was significantly associated with aortic-valve calcification; this SNP was prospectively associated with incident aortic stenosis. Mendelian randomization suggested a causal role for lipoprotein(a) in aortic-valve calcification. Valvular calc...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 368; no. 6; pp. 503 - 512
Main Authors Thanassoulis, George, Campbell, Catherine Y, Owens, David S, Smith, J. Gustav, Smith, Albert V, Peloso, Gina M, Kerr, Kathleen F, Pechlivanis, Sonali, Budoff, Matthew J, Harris, Tamara B, Malhotra, Rajeev, O'Brien, Kevin D, Kamstrup, Pia R, Nordestgaard, Børge G, Tybjaerg-Hansen, Anne, Allison, Matthew A, Aspelund, Thor, Criqui, Michael H, Heckbert, Susan R, Hwang, Shih-Jen, Liu, Yongmei, Sjogren, Marketa, van der Pals, Jesper, Kälsch, Hagen, Mühleisen, Thomas W, Nöthen, Markus M, Cupples, L. Adrienne, Caslake, Muriel, Di Angelantonio, Emanuele, Danesh, John, Rotter, Jerome I, Sigurdsson, Sigurdur, Wong, Quenna, Erbel, Raimund, Kathiresan, Sekar, Melander, Olle, Gudnason, Vilmundur, O'Donnell, Christopher J, Post, Wendy S
Format Journal Article
LanguageEnglish
Published Waltham, MA Massachusetts Medical Society 07.02.2013
Subjects
Online AccessGet full text
ISSN0028-4793
1533-4406
1533-4406
DOI10.1056/NEJMoa1109034

Cover

More Information
Summary:In a genomewide association study, a SNP in the LPA locus was significantly associated with aortic-valve calcification; this SNP was prospectively associated with incident aortic stenosis. Mendelian randomization suggested a causal role for lipoprotein(a) in aortic-valve calcification. Valvular calcification precedes the development of valvular stenosis and may represent an important early phenotype for valvular heart disease. Although aortic sclerosis is frequently considered to be a benign condition, it is associated with progression to clinical aortic stenosis 1 , 2 and with increased cardiovascular morbidity and mortality. 3 In addition, mitral annular calcification is associated with a risk of cardiovascular disease that is increased by nearly 50%. 4 Currently, there are no treatments that prevent or slow the progression of valve disease. Although genetic factors may influence the development of valvular calcification, which tends to run in families, 5 the role of common . . .
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-General Information-1
content type line 14
ObjectType-Feature-3
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
Drs. Thanassoulis, Campbell, and Owens and Drs. Gudnason, O’Donnell, and Post contributed equally to this article.
The authors’ affiliations are listed in the Appendix.
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMoa1109034